<DOC>
	<DOCNO>NCT00322543</DOCNO>
	<brief_summary>Non-randomized , single arm , multi-center , clinical trial evaluate Corio™ pimecrolimus-eluting stent reduce anti-platelet therapy patient de novo lesion native coronary artery .</brief_summary>
	<brief_title>Reduced Anti-Platelet Therapy With Pimecrolimus Drug Eluting Stent ( RAPID )</brief_title>
	<detailed_description>The registry design evaluate 6-month in-stent late lumen loss patient receive Corio™ drug-eluting stent .</detailed_description>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Pimecrolimus</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>General Inclusion Criteria 1 . Eligible percutaneous coronary intervention ( PCI ) . 2 . Documented stable unstable angina pectoris 3 . Left ventricular ejection fraction ( LVEF ) ≥25 % 4 . Acceptable candidate coronary artery bypass graft surgery ( CABG ) . 5 . Target Lesion &lt; 25 mm length RVD 2.5 3.5 mm visually estimate stenosis &gt; = 50 &lt; 100 % . General Exclusion Criteria 1 . Known sensitivity pimecrolimus , polymer ( PLGA ) cobalt chromium . 2 . Planned treatment PCI device target vessel ( ) . 3 . MI within 72 hour prior index procedure 4 . The patient cardiogenic shock . 5 . Cerebrovascular Accident ( CVA ) within past 6 month . 6 . Acute chronic renal dysfunction 7 . Contraindication ASA clopidogrel . 8 . Thrombocytopenia 9 . Active gastrointestinal ( GI ) bleed within past 3 month . 10 . Any prior true anaphylactiod reaction contrast agent 11 . Patient currently take chronic systemic steroid therapy systemic immunosuppressant therapy topical pimecrolimus . 12 . Female childbearing potential . 13 . Life expectancy le 24 month due medical condition . 14 . Comorbid condition ( ) 15 . Currently participate another investigational drug device study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Percutaneous coronary intervention ( PCI )</keyword>
	<keyword>Drug elute stent ( DES )</keyword>
</DOC>